Nidan Laboratories and Healthcare Limited (NSE:NIDAN)

NSE:NIDAN Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue	247.35	255.42	245.28	241.77	242.66	296.6
Revenue Growth	-8.78%	4.13%	1.45%	-0.36%	-18.19%	42.65%
Cost of Revenue	24.25	22.8	19.53	21.93	24.67	37.7
Gross Profit	223.1	232.62	225.74	219.84	217.99	258.9
Selling, General & Admin	43.13	43.83	46.73	48.62	51.58	38.54
Other Operating Expenses	134.04	140.13	126.71	106.78	98.37	126.22
Operating Expenses	196.42	202.94	197.53	184.06	180.94	191.07
Operating Income	26.69	29.68	28.22	35.78	37.05	67.83
Interest Expense	-19.96	-18.61	-20.66	-20.86	-20.95	-24.35
Interest & Investment Income	18.26	18.26	20.46	26.46	28.84	0.05
Other Non Operating Income (Expenses)	-0.89	-0.89	-0.73	0.05	0.48	-1.22
EBT Excluding Unusual Items	24.09	28.44	27.29	41.44	45.43	42.31
Gain (Loss) on Sale of Assets	-	-	0.32	-	2.69	2.89
Other Unusual Items	-4	-4	-	-65.13	-	-
Pretax Income	20.09	24.44	27.6	-23.69	48.12	45.2
Income Tax Expense	8.44	9.38	7.83	8.64	12.72	18.58
Net Income	11.65	15.06	19.77	-32.32	35.4	26.63
Net Income to Common	11.65	15.06	19.77	-32.32	35.4	26.63
Net Income Growth	-49.54%	-23.82%	-	-	32.92%	15.66%
Shares Outstanding (Basic)	14	14	14	14	14	11
Shares Outstanding (Diluted)	14	14	14	14	14	11
Shares Change	-0.23%	-	-	-	21.22%	15.83%
EPS (Basic)	0.84	1.08	1.42	-2.33	2.55	2.32
EPS (Diluted)	0.84	1.08	1.42	-2.33	2.55	2.32
EPS Growth	-49.57%	-23.94%	-	-	9.76%	-0.24%

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	11.01	11.9	14.2	47.84	103.01	7.53
Free Cash Flow Per Share	0.80	0.86	1.02	3.44	7.41	0.66
Gross Margin	90.20%	91.07%	92.04%	90.93%	89.83%	87.29%
Operating Margin	10.79%	11.62%	11.50%	14.80%	15.27%	22.87%
Profit Margin	4.71%	5.90%	8.06%	-13.37%	14.59%	8.98%
Free Cash Flow Margin	4.45%	4.66%	5.79%	19.79%	42.45%	2.54%
EBITDA	45.88	48.61	52.26	64.35	67.9	94.06
EBITDA Margin	18.55%	19.03%	21.31%	26.61%	27.98%	31.71%
D&A For EBITDA	19.19	18.93	24.05	28.57	30.84	26.23
EBIT	26.69	29.68	28.22	35.78	37.05	67.83
EBIT Margin	10.79%	11.62%	11.50%	14.80%	15.27%	22.87%
Effective Tax Rate	41.99%	38.38%	28.38%	-	26.44%	41.09%
Revenue as Reported	265.9	273.97	267.78	269.24	275.95	300.62

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 12, 2026

Data Sources Report a data error